Doctors and patients weigh in: what matters most in lung cancer care?

NCT ID NCT06448793

Recruiting now Knowledge-focused Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

Summary

This study aims to understand what patients and their doctors value when choosing treatments for early-stage, operable lung cancer. Researchers will conduct 15-minute interviews with 55 participants, including patients and healthcare professionals from the US, Germany, and Japan. The goal is to gather opinions and preferences to help inform future treatment development and decision-making, not to test any new therapies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER (NSCLC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Evidera
RECRUITING

London, United Kingdom

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER (NSCLC)